Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma

This study has been withdrawn prior to enrollment.
(Strategic reasons: Sponsor seeks oncology partner to explore Prolarix potential)
Sponsor:
Information provided by:
BTG International Inc.
ClinicalTrials.gov Identifier:
NCT00746590
First received: September 3, 2008
Last updated: July 15, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2009
  Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)